United States · FDA National Drug Code directory
Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-408_1b25114a-fb04-4ec5-a5c0-6868f36116d6
- Product NDC
- 72603-408
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- Paclitaxel
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250910
- Source listing expiry
- 20261231
Source-listed ingredients
- PACLITAXEL — 100 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (72603-408-01) / 20 mL in 1 VIAL, SINGLE-USE · 72603-408-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →